$2.76T
Total marketcap
$203.01B
Total volume
BTC 50.80%     ETH 16.38%
Dominance

BB Biotech AG BBAGF Stock

47.8 USD {{ price }} 2.795697% {{change_pct}}%
Exchange
Other OTC
Market Cap
3.67B USD
LOW - HIGH [24H]
47.8 - 47.8 USD
VOLUME [24H]
1 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-17.292 USD

BB Biotech AG Price Chart

BB Biotech AG BBAGF Financial and Trading Overview

BB Biotech AG stock price 47.8 USD
Previous Close 55 USD
Open 55 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 55 - 55 USD
52 Week Range 54 - 63.5 USD
Volume 300 USD
Avg. Volume 273 USD
Market Cap 4.22B USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -17.292 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

BBAGF Valuation Measures

Enterprise Value 3.02B USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.122999
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

BB Biotech AG Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -13.38%
S&P500 52-Week Change 20.43%
52 Week High 63.5 USD
52 Week Low 54 USD
50-Day Moving Average 59.57 USD
200-Day Moving Average 59.57 USD

BBAGF Share Statistics

Avg. Volume (3 month) 273 USD
Avg. Daily Volume (10-Days) 403 USD
Shares Outstanding 55.4M
Float N/A
Short Ratio N/A
% Held by Insiders 1.76%
% Held by Institutions 7.75%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 4K USD
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -17.292
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) 48.976

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of BB Biotech AG

Country United States
State N/A
City Kusnacht
Address Seestrasse 16
ZIP 8700
Phone 41 44 267 67 00
Website https://www.bbbiotech.ch/en/bb-biotech/
Industry
Sector(s)
Full Time Employees 10

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Q&A For BB Biotech AG Stock

What is a current BBAGF stock price?

BB Biotech AG BBAGF stock price today per share is 47.8 USD.

How to purchase BB Biotech AG stock?

You can buy BBAGF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BB Biotech AG?

The stock symbol or ticker of BB Biotech AG is BBAGF.

How many shares does BB Biotech AG have in circulation?

The max supply of BB Biotech AG shares is 76.79M.

What is BB Biotech AG Price to Earnings Ratio (PE Ratio)?

BB Biotech AG PE Ratio is now.

What was BB Biotech AG earnings per share over the trailing 12 months (TTM)?

BB Biotech AG EPS is -17.292 USD over the trailing 12 months.